Mirae Asset Venture Investment Eyes at Least Threefold Returns as Portfolio Companies Prepare for Second-Half Listings

Mirae Asset Venture Investment announced on the 21st that four of its portfolio companies-Semifive, CMTX, Livesmed, and Teraview-recently received preliminary approval from the Korea Exchange for listing on the KOSDAQ, clearing a major hurdle toward going public.

Semifive is expected to directly benefit from the growth of the domestic AI and semiconductor industries, alongside companies such as Rebellions and Exyna. The government is actively supporting not only AI models but also the overall competitiveness of the domestic semiconductor industry as part of its "Sovereign AI" initiative, and Semifive is regarded as one of the main beneficiaries of this policy. The recovery of Samsung Foundry is also noteworthy. Global big tech companies, including Tesla, are reportedly considering Samsung Foundry as an alternative, as they have grown weary of TSMC's excessive dominance. If these companies adopt Samsung Foundry, Semifive is expected to play a core role in Korea similar to that of Broadcom and could see significant benefits.

CMTX does not manufacture semiconductors directly, but specializes in producing key consumables such as silicon rings and electrodes used in etching process equipment. Its main competitive advantages include precision processing technology and the ability to secure stable, competitively priced silicon ingots-the raw material-through its subsidiary. CMTX is a primary supplier to major domestic fabs and, notably, is the first and only Korean company selected as a primary supplier to TSMC, providing products for its 2-3 nanometer advanced process lines. The expansion of the AI industry has led to a surge in HBM and high-performance DRAM production, resulting in higher factory utilization rates and substantial performance growth. In 2024, CMTX recorded sales of 108.7 billion won and operating profit of 23.6 billion won. For the first half of this year, sales reached 77.3 billion won and operating profit was 26.3 billion won, representing year-on-year increases of 93% and 417%, respectively.

Livesmed, a company specializing in laparoscopic surgical devices and surgical robots, also recently received preliminary approval for KOSDAQ listing. Livesmed developed "ArtiSential," the world's first multi-joint laparoscopic surgical instrument capable of 90-degree rotation in all directions. While traditional laparoscopic instruments were closer to simple forceps, making precise manipulation difficult, ArtiSential is recognized as a significant technological advancement. It delivers high levels of operability and precision while reducing costs to one-tenth of conventional devices, and is exported to 250 hospitals in Korea and 72 countries worldwide. Meanwhile, the company's next-generation robotic surgery product, STARK, replicates ArtiSential's precise control and flexible joint movement. Recently, Livesmed successfully completed a 3,000 km long-distance remote surgery demonstration in collaboration with the US telemedicine company SOVATO.

In addition, Teraview, an ultra-precision inspection equipment and technology company invested in by Mirae Asset Venture Investment, submitted its securities registration statement to the Financial Services Commission on the 15th, officially launching its KOSDAQ listing process. Teraview is the first UK-based company to pursue a KOSDAQ listing. Its headquarters are in Cambridge, UK, with a Korean office in Seoul. The company provides ultra-precision inspection equipment and technology services (solutions) based on "terahertz" technology, which can detect minute cracks and defects invisible to the naked eye. Terahertz technology is in high demand in advanced manufacturing industries where high-precision inspection is essential, such as semiconductors, secondary batteries, electric vehicles, and aerospace. Not only do domestic companies like Samsung Electronics, SK Hynix, and Samsung SDI use Teraview's inspection equipment, but global companies such as Nvidia, TSMC, Intel, Tesla, and Apple also utilize its solutions.

Mirae Asset Venture Investment is reported to have invested more than 50 billion won in each of these four companies, and with their listings scheduled for the second half of the year, significant investment returns are expected. This is why the company's performance in the latter half of the year is highly anticipated.